Correlation Between Bolt Biotherapeutics and Annexon

Can any of the company-specific risk be diversified away by investing in both Bolt Biotherapeutics and Annexon at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bolt Biotherapeutics and Annexon into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Bolt Biotherapeutics and Annexon, you can compare the effects of market volatilities on Bolt Biotherapeutics and Annexon and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bolt Biotherapeutics with a short position of Annexon. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bolt Biotherapeutics and Annexon.

Diversification Opportunities for Bolt Biotherapeutics and Annexon

0.82

Correlation Coefficient

Bolt Biotherapeutics  Annexon

Very poor diversification

The 3 months correlation between Bolt and Annexon is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding Bolt Biotherapeutics and Annexon in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Annexon and Bolt Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bolt Biotherapeutics are associated (or correlated) with Annexon. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Annexon has no effect on the direction of Bolt Biotherapeutics i.e., Bolt Biotherapeutics and Annexon go up and down completely randomly.

Pair Corralation between Bolt Biotherapeutics and Annexon

Given the investment horizon of 90 days Bolt Biotherapeutics is expected to generate 0.67 times more return on investment than Annexon. However, Bolt Biotherapeutics is 1.49 times less risky than Annexon. It trades about -0.11 of its potential returns per unit of risk. Annexon is currently generating about -0.25 per unit of risk. If you would invest  57.00  in Bolt Biotherapeutics on December 28, 2024 and sell it today you would lose (13.00) from holding Bolt Biotherapeutics or give up 22.81% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Bolt Biotherapeutics  vs.  Annexon

Bolt Biotherapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Bolt Biotherapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's essential indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Annexon

Risk-Adjusted Performance

Very Weak

Over the last 90 days Annexon has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Bolt Biotherapeutics and Annexon

The main advantage of trading using opposite Bolt Biotherapeutics and Annexon positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bolt Biotherapeutics position performs unexpectedly, Annexon can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Annexon will offset losses from the drop in Annexon's long position.

The idea behind Bolt Biotherapeutics and Annexon pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.